These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27273676)

  • 21. Using nimodipine for patients with aneurysmal subarachnoid hemorrhage.
    Rank W
    Nursing; 2014 Jan; 44(1):67. PubMed ID: 24346375
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pre-ictal antiplatelet therapy use in aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Ogulnick J; Feldstein E; Damodara N; Bravo M; Alshammari H; Dominguez J; Cooper J; Huang KT; Marikunte S; Ali S; Patel V; Khandelwal P; Mayer SA; Amuluru K; Gandhi CD
    Clin Neurol Neurosurg; 2021 Dec; 211():107022. PubMed ID: 34781219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.
    Feigin VL; Rinkel GJ; Algra A; Vermeulen M; van Gijn J
    Neurology; 1998 Apr; 50(4):876-83. PubMed ID: 9566366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
    Vázquez-Medina A; Turnbull MT; James CL; Cowart JB; Lesser E; Carter RE; Ross OA; Miller DA; Meschia JF; De Jesús Espinosa A; Weinshilboum R; Freeman WD
    Pharmacogenomics J; 2024 Jun; 24(4):19. PubMed ID: 38890281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
    Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
    Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
    J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics of Cytochrome P450 of Nimodipine Metabolism After Aneurysmal Subarachnoid Hemorrhage.
    Peacock SH; James C; Turnbull MT; Cowart JB; Reid JM; Freeman WD
    J Neurosci Nurs; 2019 Oct; 51(5):238-242. PubMed ID: 31469704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium antagonists for aneurysmal subarachnoid haemorrhage.
    Dorhout Mees SM; Rinkel GJ; Feigin VL; Algra A; van den Bergh WM; Vermeulen M; van Gijn J
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD000277. PubMed ID: 17636626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.
    Adams HP
    Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
    Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL;
    Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometry-based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage.
    Mindt S; Tokhi U; Hedtke M; Groß HJ; Hänggi D
    J Clin Pharm Ther; 2020 Feb; 45(1):81-87. PubMed ID: 31421063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does nimodipine influence sex difference in outcome after aneurysmal subarachnoid haemorrhage?
    Hauerberg J; Rosenørn J; Skriver EB
    Acta Neurochir (Wien); 1996; 138(10):1168-71. PubMed ID: 8955435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposal of a Grading System for Predicting Discharge Mortality and Functional Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Maragkos GA; Enriquez-Marulanda A; Salem MM; Ascanio LC; Chida K; Gupta R; Alturki AY; Kicielinski KP; Ogilvy CS; Moore JM; Thomas AJ
    World Neurosurg; 2019 Jan; 121():e500-e510. PubMed ID: 30268551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Neurological Outcomes Related to Aneurysmal Subarachnoid Hemorrhage and Onsite Access to Neurointerventional Radiology.
    Mogollon JP; Smoll NR; Panwar R
    World Neurosurg; 2018 May; 113():e29-e37. PubMed ID: 29410100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage.
    Stiefel MF; Heuer GG; Abrahams JM; Bloom S; Smith MJ; Maloney-Wilensky E; Grady MS; LeRoux PD
    J Neurosurg; 2004 Oct; 101(4):594-9. PubMed ID: 15481712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quadriceps muscle thickness changes in patients with aneurysmal subarachnoid hemorrhage during the acute phase.
    Nozoe M; Kanai M; Kubo H; Kobayashi M; Yamamoto M; Shimada S; Mase K
    Top Stroke Rehabil; 2018 Apr; 25(3):209-213. PubMed ID: 29216792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of Modified Nimodipine Dosing in Aneurysmal Subarachnoid Hemorrhage.
    Mahmoud L; Zullo AR; Blake C; Dai X; Thompson BB; Wendell LC; Furie KL; Reznik ME; Mahta A
    World Neurosurg; 2022 Feb; 158():e501-e508. PubMed ID: 34775086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early-phase pharmacokinetics of enteral and parenteral nimodipine in patients with acute subarachnoid haemorrhage - a pilot study.
    Soppi V; Kokki H; Koivisto T; Lehtonen M; Helin-Tanninen M; Lehtola S; Rinne J
    Eur J Clin Pharmacol; 2007 Apr; 63(4):355-61. PubMed ID: 17318527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.
    Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI
    Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.